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Objective. For many individuals with chronic low
back pain (CLBP), there is no identifiable cause. In
other idiopathic chronic pain conditions, sensory test-
ing and functional magnetic resonance imaging (fMRI)
have identified the occurrence of generalized increased
pain sensitivity, hyperalgesia, and altered brain pro-
cessing, suggesting central augmentation of pain pro-
cessing in such conditions. We compared the results of
both of these methods as applied to patients with
idiopathic CLBP (n  11), patients with widespread
pain (fibromyalgia; n  16), and healthy control sub-
jects (n  11).
Methods. Patients with CLBP had low back pain
persisting for at least 12 months that was unexplained
by MRI/radiographic changes. Experimental pain test-
ing was performed at a neutral site (thumbnail) to
assess the pressure-pain threshold in all subjects. For
fMRI studies, stimuli of equal pressure (2 kg) and of
equal subjective pain intensity (slightly intense pain)
were applied to this same site.
Results. Despite low numbers of tender points in
the CLBP group, experimental pain testing revealed
hyperalgesia in this group as well as in the fibromyalgia
group; the pressure required to produce slightly intense
pain was significantly higher in the controls (5.6 kg)
than in the patients with CLBP (3.9 kg) (P  0.03) or
the patients with fibromyalgia (3.5 kg) (P  0.006).
When equal amounts of pressure were applied to the 3
groups, fMRI detected 5 common regions of neuronal
activation in pain-related cortical areas in the CLBP
and fibromyalgia groups (in the contralateral primary
and secondary [S2] somatosensory cortices, inferior
parietal lobule, cerebellum, and ipsilateral S2). This
same stimulus resulted in only a single activation in
controls (in the contralateral S2 somatosensory cortex).
When subjects in the 3 groups received stimuli that
evoked subjectively equal pain, fMRI revealed common
neuronal activations in all 3 groups.
Conclusion. At equal levels of pressure, patients
with CLBP or fibromyalgia experienced significantly
more pain and showed more extensive, common pat-
terns of neuronal activation in pain-related cortical
areas. When stimuli that elicited equally painful re-
sponses were applied (requiring significantly lower
pressure in both patient groups as compared with the
control group), neuronal activations were similar
among the 3 groups. These findings are consistent with
the occurrence of augmented central pain processing in
patients with idiopathic CLBP.
Chronic low back pain (CLBP) is one of the most
common and expensive musculoskeletal disorders in
developed countries (1,2). Back pain in general affects
70–85% of all people at some time in their lives, but 90%
of affected individuals recover, typically within 12 weeks
(3). Recovery after 12 weeks is slow and uncertain, and this
subset of patients with CLBP accounts for major expenses
in the health care and disability systems (2,4).
Despite the magnitude of the problem, little is
known about the precise cause of CLBP. There is often
a mismatch between objective findings and symptoms.
Despite advances in imaging, in most patients, it is
impossible to determine whether identifiable structural
or mechanical abnormalities are responsible for the
symptoms (5,6). Moreover, even when anatomic abnor-
malities are detected, the significance is unclear, since
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bulging disks or annular tears are found in high percent-
ages of asymptomatic individuals (7,8).
This mismatch between anatomic abnormalities
and symptoms has led to studies of the psychosocial
factors that may contribute to CLBP. These studies
suggest that increasing age, female sex, lower levels of
formal education, depression, stress, job dissatisfaction,
and disability/compensation issues may play some role in
expression of symptoms and in chronicity (9–13). How-
ever, all of the known anatomic, demographic, and
psychosocial factors that might cause CLBP do not
explain the symptoms in a significant number of subjects
(14,15). These individuals are sometimes referred to as
having “idiopathic” or “nonspecific” CLBP.
Pain in other idiopathic chronic pain conditions,
such as irritable bowel syndrome and fibromyalgia syn-
drome (FMS), appears to result from abnormalities in
pain processing rather than from damage or inflamma-
tion of peripheral structures. A common finding in these
and other “central” or “non-nociceptive” pain syn-
dromes is increased tenderness to pressure, which can be
classified as mechanical hyperalgesia (i.e., increased
pain in response to normally painful stimuli) and/or
mechanical allodynia (i.e., pain in response to normally
nonpainful stimuli) (16,17). These abnormalities are
found even in the absence of any identifiable psycholog-
ical or behavioral factors, thus implicating central mech-
anisms that exacerbate pain (e.g., “wind-up”) or that
attenuate pathways that begin in the brain stem and
normally inhibit the ascending transmission of pain-
related activity (18–20).
The finding of augmented stimulation-evoked
pain, assessed by patient self-report, has recently been
corroborated by functional brain imaging techniques
that allow the visualization of structures that are poten-
tially involved in pain processing. These methods infer
increased neural activity from highly localized increases
in regional cerebral blood flow that are produced in
response to anticipated metabolic demands. These
methods can involve infusion of radioactive tracers
(21,22) or, in the case of functional magnetic resonance
imaging (fMRI), the magnetic character of the level of
oxygen in the blood is used as an indirect, intrinsic tracer
(23). Functional imaging studies have shown that painful
stimulation produces increased neural activity in struc-
tures involved in the processing of sensation, movement,
cognition, and emotion (22,24,25). Functional imaging
studies in chronic pain states that are characterized by
hyperalgesia/allodynia have corroborated patients’ self-
reports of mechanical hyperalgesia, identifying objective
evidence of augmented responses to pressure stimuli
(such as in the viscera and periphery in irritable bowel
syndrome and FMS, respectively) (26,27).
In a recent cross-sectional study of CLBP, we
demonstrated that a simple laboratory measure of
pressure-pain sensitivity was the best correlate of pain
and functional status, exceeding the predictive value of
any other demographic, psychological, or radiographic
variable (15). In the present study, we have expanded on
this work and performed both experimental pain testing
and functional imaging in a cohort of patients with
CLBP. This particular cohort was specifically identified
to have idiopathic CLBP, i.e., individuals without evi-
dence of any anatomic abnormalities on MRI or plain
radiographs that could explain these symptoms. These
patients were compared with both a normal healthy
control group and a cohort of individuals with FMS.
PATIENTS AND METHODS
Patients and control subjects. The study was con-
ducted at Georgetown University Hospital, and patients were
recruited from tertiary care spine and fibromyalgia centers.
Sixteen right-handed adult patients scheduled for a visit for
low back pain were recruited from a sample of consecutive
clinic patients. The inclusion criterion in this group was that
low back pain be the dominant symptom. In accordance with
the generally accepted definition of CLBP (28), the duration of
pain had to be at least 12 weeks. Idiopathic low back pain was
diagnosed according to the guidelines and exclusion criteria
recommended by Deyo and Weinstein (1). These exclusion
criteria included pain in areas other than the lower back,
evidence of a fracture (including vertebral fractures due to
osteoporosis) or malignancy that may account for the pain,
inflammatory joint disease, or previous neck or back surgery.
Radiographs and MRI scans of the spine were ob-
tained and evaluated by a physician (AN) who was not familiar
with either the patients or the results of testing. The radio-
graphs were graded using the system developed by Weiner and
colleagues (29), and the MRI scans were graded using the
technique described by Videman and colleagues (30). There is
no rating scale for radiographic or MRI studies that is perfect
in estimating the degree of patho-anatomic abnormality in
CLBP. We concluded that the above-noted standardized ap-
proaches were the best of those published, and that it would be
preferable to use these established methods rather than design
a unique scale for use in this study.
Seventeen right-handed patients (13 women, 4 men;
mean  SD age 45  12 years) who met the 1990 American
College of Rheumatology (ACR) criteria for FMS (31) at the
time of the study were randomly selected from a sample of
consecutive clinic patients. These patients formed the FMS
group. In addition, 15 right-handed, healthy subjects were
recruited through newspaper advertisements and were com-
pensated for their participation; these subjects served as
controls.
Subjects were screened by a medical history review and
physical examination. General exclusion criteria for all subjects
were severe physical impairment (e.g., bilateral amputation,
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complete blindness or deafness), medical conditions that were
capable of causing patients’ symptoms (e.g., morbid obesity,
autoimmune/inflammatory diseases), cardiopulmonary disor-
ders (i.e., angina, congestive heart failure, chronic obstructive
pulmonary disease, chronic asthma), chronic renal insuffi-
ciency, uncontrolled endocrine or allergic disorders (i.e.,
hyper-/hypothyroidism, diabetes, allergic rhinitis), malignancy,
severe psychiatric illnesses (e.g., current schizophrenia, sub-
stance abuse within 2 years), factors known to affect the
hypothalamic–pituitary–adrenal axis or autonomic function
(cigarette smoking, daily intake of caffeine exceeding the
equivalent of 2 cups of coffee), and medication usage other
than as-needed analgesics (excluding long-term narcotics) and
appropriate dosages of thyroid hormone. Patients were asked
to discontinue intake of antidepressants up to 4 weeks ahead of
the appointment (depending on the half-life of the drug), but
were allowed to take nonsteroidal antiinflammatory drugs
until 3 days before the baseline psychophysical evaluation and
the fMRI sessions. Patients receiving long-term opioid medi-
cations were excluded.
All subjects gave their written informed consent before
testing. The protocol was approved by the Georgetown Uni-
versity Institutional Review Board.
Self-report questionnaires. Center for Epidemiological
Studies Depression Scale (CES-D). The CES-D is an extensively
evaluated 20-item instrument that has good psychometric
properties and strong associations with other measures of
depressive symptoms (32).
State-Trait Personality Inventory (STPI). A 20-item sub-
set of the STPI (Form Y) was used to assess trait anxiety.
These items of the STPI have been well-validated as part of
larger instruments, such as the State-Trait Anxiety Inventory
and the State-Trait Anger Inventory (33).
Pain location.To determine each subject’s distribution
of pain, we administered a graphic display representing the
front and back of the body (34). To quantify the results, the
front of the body was divided into 34 symmetric sections plus
the eyes and groin, and the back was divided into 26 symmetric
sections plus the anus/rectum. Each section contained a cor-
responding circle. Subjects were asked to indicate the sections
in which they typically experienced pain by filling in the
corresponding circle. They were instructed to fill in as many
circles as applicable to the areas where they typically experi-
enced the pain.
Clinical pain. The experience of clinical pain in subjects
was assessed using the Short-Form of the McGill Pain Ques-
tionnaire (SF-MPQ) (35). This questionnaire has been exten-
sively evaluated and contains 15 pain adjectives. A sensory
score is obtained by summing 11 of the items, an affective score
is obtained by summing the remaining 4 items, and a total
score is obtained by summing all of the items.
Experimental pain assessment. In a pre-fMRI baseline
session, a well-trained and experienced research assistant
performed the manual tender point count. Pressure was ap-
plied with the dominant thumb at the locations defined by the
ACR criteria. Pressure was increased by 1 kg/second up to 4
kg, while making a rotating, massaging movement with the
thumb. After the pressure was released, the patient was asked:
“Was that painful?”
The tender point count was followed by a determina-
tion of pressure-pain sensitivity by subjective scaling of multi-
ple pressure-pain sensations of suprathreshold intensities. Dis-
crete, 5-second pressure stimuli were applied with a 1-cm2 hard
rubber probe to the fixated left thumbnail. Previous studies
have shown that “neutral” regions such as the thumb accu-
rately reflect an individual’s overall pressure-pain sensitivity
(36). The rubber probe was attached to a hydraulic piston, a
combination of valves (to control stimulus duration), and a
scale. Calibrated weights were placed on the scale to produce
controlled, repeatable pressure-pain stimuli of rectangular
waveform at the thumbnail. Subjects rated the intensity of
pressure-pain sensations using a combined numeric analog
descriptor scale, developed from previously quantified verbal
descriptors (37). First, a series of stimuli was presented in a
predictable, “ascending” manner, beginning at 0.5 kg/cm2 and
increasing in 0.5-kg/cm2 intervals up to tolerance or to a
maximum of 10 kg/cm2. Following the ascending series, 36
stimuli were delivered at 20-second intervals in random order,
using the multiple random staircase (MRS) method (38). The
MRS method is response-dependent, i.e., it determines the
stimulus intensity needed to elicit a specified response.
Functional imaging. MRI and fMRI scans were per-
formed on a 1.5-Tesla vision system (Siemens, Munich, Ger-
many). A T1-weighted MRI anatomic scan session (time to
echo [TE] 4 mseconds, time to recovery [TR] 9.7 mseconds,
flip angle 12°, 256  256-pixel matrix, field of vision [FOV] 256
mm, 1-mm3 voxels acquired noninterleaved in the sagittal
direction) was followed by 2 functional scan sessions using
multislice echo-planar imaging fMRI acquisition (TE 40 msec-
onds, TR 5 seconds, repetition time 5 seconds, flip angle 90°,
64  64-pixel matrix, FOV 192 mm, 50 horizontal 3-mm
slices). These parameters allowed coverage of the entire brain
with 3-mm3 voxels within 5 seconds.
During each functional scan session, the whole brain
was scanned 128 times. Three initial scans allowed for satura-
tion of the tissue. Starting on the fourth scan, pressure stimuli
of 25 seconds’ duration (“on” condition) were alternated with
25-second resting periods (“off” condition). Onset and offset
of a stimulus was always coincident with the beginning of a
scan, allowing the acquisition of 5 scans during each “on”
condition and each “off” condition.
During the “on” condition, different stimulus intensi-
ties were presented in a random manner. These stimulus
intensities included three 2-kg stimuli that constituted the
equal pressure condition, and 3 stimuli, chosen on the basis of
the baseline pain testing, that were sufficient to elicit a rating
of 13.5 of 20 units (slightly intense pain), thus constituting the
equal pain condition. The analysis was performed on the scans
acquired during the equal pressure condition, the equal pain
condition, and the “off” conditions.
Statistical analysis. Statistical analyses were per-
formed using SPSS for Windows (SPSS, Chicago, IL). Group
comparisons with not normally distributed data (tender point
counts, duration of symptoms, body mass index) were per-
formed using the Kruskal-Wallis test. Normally distributed
data were compared using one-way analysis of variance, fol-
lowed by Gabriel’s procedure when variances were found
equal, and by the Games-Howell procedure when variances
were unequal. Homogeneity of variances was tested using
Levene’s test. A P value of less than 0.05 was generally
considered significant.
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Imaging analysis. Imaging data were analyzed with
MEDx (Sensor Systems, Sterling, VA). The functional images
were corrected for head motion and intensity differences.
Excessive head motion was determined by motion detection
software and visual inspection of raw and processed images.
Acceptable motion-corrected images were spatially smoothed
at 6-mm full width at half maximum.
The brain volumes collected during equal pressure and
equal pain conditions were compared with the brain volumes
collected during “off” conditions by t-test, and a Z-map (with
a Z score for each voxel) was created for each subject. The Z
score is a value that indicates a distribution, with a mean of zero,
and each integer indicates a standard deviation of 1 (e.g., a Z
score of 2 indicates 2 SD above the mean, a Z score of 3 is 3 SD
below the mean). Results for fMRI are commonly presented as Z
scores. Resultant Z-maps were registered into standardized space
using the statistical parametric mapping (SPM96) echo-planar
imaging template and resliced to 2-mm3 voxels.
Group Z-maps were computed from the sum of indi-
vidual Z-maps of both functional runs divided by the square
root of the number of scans. Activations were considered
significant at a P value less than 0.05, corrected for multiple
comparisons using the random Gaussian field theory correc-
tion (39). The search volume consisted of “pain-relevant”
regions determined in previous studies (27).
Anatomic regions were identified by the following: 1)
inspection of individual functional images superimposed on an
individual structural image, and 2) conversion of the coordi-
nates to the coordinate system of the Talairach-Tournoux
Atlas and localization using this Atlas (40) and automated
software (41).
RESULTS
After grading the radiographs and MRI scans, 2
patients with disc extrusion, 1 patient with spinal steno-
sis, and 1 patient with spondylolisthesis were excluded
from the CLBP group because of possible neural com-
promise. Of the remaining 12 patients with CLBP, 6
were assigned a global assessment grade of 1 from their
radiographs (scale 1–4), with maximum grade 1 disc
degeneration from L3 to S1. Six patients with CLBP had
a global assessment grade of 2, with grade 2 to grade 3
disc degeneration from L3 to S1. In the MRI evalua-
tions, none of the patients with CLBP had disc protru-
sion or any other visible cause of neural compromise,
none had a disc-height reduction of more than 50%, and
none had more than grade 1 endplate degeneration
(scale 0–3).
One patient with CLBP declined to undergo the
fMRI procedure, and for 1 patient with FMS and 4
control subjects, the imaging results for both conditions
could not be interpreted because of excessive head
motion. Therefore, the data for these 6 subjects were
Table 1. Group characteristics and results of pressure-pain testing*
Healthy controls (n  11) CLBP patients (n  11) FMS patients (n  16)
Demographic
Sex no. male/no. female 7/4 3/8 4/12
Age, years 41  7 44  13 45  12
Median (range) BMI, kg/m2 25 (20–30) 24 (17–32) 28 (21–36)
Median (range) duration of
symptoms, months
– 54 (12–312) 86 (12–300)
No. of pain locations (maximum 63) 0.8  1.4 10.1  6.0† 32.4  9.8‡
No. of tender points 3.2  5.3 3.3  3.2 15.1  2.9‡
Depressive symptoms score on CES-D 4.8  5.9 11.5  7.5 17.8  11.9‡
Anxiety score on STPI 15  4.4 18.5  4.4 21.8  7.3†
Clinical pain
SF-McGill sensory 0 6.2  5.7‡ 8.5  5.2‡
SF-McGill affective 0 1.6  1.7‡ 2.3  1.8‡
SF-McGill total 0 7.8  6.9‡ 10.8  6.3‡
Pain testing results
Pain threshold, kg 2.7  2.1 0.7  0.5§ 0.7  0.5§
Moderate pain, kg 5.3  2.8 2.7  2.7§ 2.2  1.4†
Slightly intense pain, kg 7.3  1.7 4.9  2.4§ 4.1  2.5†
fMRI scanner results
Equal pressure, kg 2.0 2.0 2.0
Pain intensity rating (maximum 20) 1  1.1 6  4.2§ 6  4.2§
Equal pain intensity, kg 5.6  1.7 3.9  1.3§ 3.5  1.6†
Pain intensity rating (maximum 20) 14  3.8 16  1.5 16  2.3
* Values are the mean  SD, except where indicated otherwise. CLBP  chronic low back pain; FMS  fibromyalgia
syndrome; BMI  body mass index; CES-D  Center for Epidemiological Studies Depression Scale; STPI  State-Trait
Personality Inventory; SF-McGill  Short-Form of the McGill Pain Questionnaire; fMRI  functional magnetic resonance
imaging.
† P  0.01 versus healthy controls.
‡ P  0.001 versus healthy controls.
§ P  0.05 versus healthy controls.
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excluded from the analysis. Eleven patients with CLBP,
16 patients with FMS, and 11 control subjects formed
the final study population. Table 1 shows the character-
istics of the 3 study groups.
The ethnic representation was comparable in the
groups. The CLBP group and the control group each
had 8 whites (73%), 2 African Americans (18%), and 1
Hispanic (9%). The FMS group had 11 whites (69%), 3
African Americans (19%), and 2 Hispanics (13%).
Both patient groups reported significantly more
clinical pain on the SF-MPQ as compared with that
reported by the controls. However, there was no signif-
icant difference in the level of clinical pain between the
patients with CLBP and those with FMS. These results
are shown in Table 1.
Table 1 also shows the expected greater extent of
pain, measured by a pain body map, in the patients with
FMS (mean 32.4 sites indicated as painful, of a possible
63 body sites) compared with that in the patients with
CLBP (mean 10.1 sites indicated as painful, mainly in
the low back) and healthy controls (mean 0.8 sites
indicated as painful). As expected, the patients with FMS
also reported greater numbers of tender points (mean 
SD 15.1  2.9, of 18 possible), whereas the tender point
counts were nearly equal between the CLBP group (mean
3.3) and healthy controls (mean 3.2).
Similar to the differences in the tender point
count, the FMS group displayed significantly higher
levels of psychological distress than did the healthy
control group, as measured by their depression and
anxiety scores. Although there was a trend toward
higher levels of anxiety and depression in the CLBP
group, neither the difference from the patients with
FMS nor the difference from the healthy control group
was statistically significant.
The results of the more sophisticated experimen-
tal pain-testing procedures are also shown in Table 1.
Despite the higher tender point counts in the patients
with FMS, both patient groups displayed similar pain
Figure 1. Stimulus-response functions in all 3 groups, obtained by
psychophysical pain testing using the multiple random staircase para-
digm. Stimulus intensities for pain thresholds and suprathreshold
stimuli sufficient to elicit a rating of moderate pain (7.5 of 20 units on
the Gracely pain box scale) and slightly intense pain (13.5 of 20 units
on the Gracely pain box scale) are shown for each group. Both the
chronic low back pain (CLBP) and fibromyalgia syndrome (FMS)
patient groups show a significant lowering of the stimulus response,
with almost identical slopes. HC  healthy controls.   P  0.05
versus patient groups.
Table 2. Areas of neuronal activations at the equal pressure (2 kg) condition*
Side, cortical region, group x y z Z score
Contralateral
Primary somatosensory
CLBP 57 13 43 7.73632
FMS 59 15 43 5.15532
Secondary somatosensory
HC 61 18 21 4.20553
CLBP 55 22 18 7.23976
FMS 65 28 16 5.02477
Ipsilateral
Secondary somatosensory
CLBP 65 15 12 5.86164
FMS 59 17 10 4.77318
Inferior parietal
CLBP 46 44 56 4.45876
FMS 40 46 59 4.44034
Cerebellum
CLBP 32 57 21 3.55417
FMS 30 56 22 5.27124
* Values for x, y, and z are standard coordinates (in mm) in the 3-dimensional Talairach space (40).
CLBP  chronic low back pain; FMS  fibromyalgia syndrome; HC  healthy controls.
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thresholds at the left thumb and these were significantly
lower than that of the healthy control group. Similarly,
the suprathreshold pressure intensities sufficient to
evoke moderate or slightly intense pain were signifi-
cantly lower in the patient groups compared with the
healthy control group (Figure 1).
Correspondingly, pressure intensities adapted to
evoke slightly intense pain on the fMRI scanner were
significantly lower in both patient groups than in the
control group (mean  SD pressure intensity in patients
with CLBP 3.9  1.3 kg, patients with FMS 3.5  1.6 kg,
and healthy controls 5.6  1.7 kg; P  0.05). Pain intensity
ratings obtained immediately after each scanning session
confirmed that these stimuli evoked equally painful sensa-
tions (mean  SD [of a maximum 20] pain intensity rating
in patients with CLBP 15.8  1.5, patients with FMS
15.8  2.3, and healthy controls 14.3  3.8). Figure 1
displays the similar lowering of pain thresholds in both
patient groups as compared with the healthy control group.
The fMRI analyses of the response under the
equal pressure condition revealed that in both the
patients with CLBP and patients with FMS, 2 kg pres-
sure resulted in ratings of moderate pain and led to an
increase in the fMRI signal in the contralateral primary
(S1) and secondary (S2) somatosensory cortices, ipsilat-
eral S2, inferior parietal lobule (IPL), and cerebellum.
In contrast, this same 2-kg stimulus in the healthy
control group produced a rating of only faint pain and
resulted in an increase in the fMRI signal in only the
contralateral S2 cortical region. Table 2 shows the
Figure 2. Overlapping neuronal activations under the equal stimulus condition. In the chronic low back pain (CLBP),
fibromyalgia syndrome (FMS), and healthy control (HC) groups under the equal pressure condition, significant increases
in pain-related neuronal activations (arrows) are demonstrated in standard space superimposed on a structural
T1-weighted magnetic resonance image. Images are shown in radiologic view, with the right brain shown on the left.
Overlapping activations appear in the indicated colors. Equal pressure intensities result in 5 overlapping areas of neuronal
activation in the CLBP and FMS groups (in the contralateral S1, S2, and inferior parietal lobule [IPL], and in ipsilateral
S2 and cerebellum), but in only 1 overlapping area of neuronal activation among the HC, CLBP, and FMS groups (in the
contralateral S2).
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anatomic locations, standard coordinates, and Z scores
for these neuronal activations. Figure 2 shows the areas
of overlapping activation in the brain.
In contrast to the results obtained at equal pres-
sure intensities, all 3 groups tested under the equal pain
condition (slightly intense pain) showed significant in-
creases in the fMRI signal in the contralateral S1, S2,
IPL, insula, and anterior cingulate cortex (ACC), and in
ipsilateral S2 and cerebellum. Table 3 shows the ana-
tomic locations, standard coordinates, and Z scores for
these neuronal activations under equal pain. Figure 3
shows the areas of overlapping activation in the brain.
Although the groups were not significantly differ-
ent with regard to age, there was a sex mismatch
between the control group and the patient groups. To
ensure that our results were not due to this imbalance in
the sexes, we evaluated the association of sex with the
individual pain thresholds as well as the individual mean
differences between the equal pressure condition, the
equal pain condition, and the “off” conditions of the
fMRI experiment. In addition, we performed t-tests of
pain thresholds and fMRI mean differences between
men and women in all 3 groups. No significant correla-
tions were found between sex and any of these variables
(r  0.12–0.25, P  0.4–0.7). Likewise, none of the
t-tests showed any significant differences in pressure
sensitivity or fMRI signal between the men and the
women within the groups.
DISCUSSION
The experimental pain testing performed in this
study suggests that a subset of individuals with idiopathic
CLBP have increased pressure-pain sensitivity at a site
distant from their region of clinical pain (in this case, the
thumb). Functional MRI, which allows visualization of
changes in regional cerebral blood flow associated with
the application of painful stimuli, corroborated the fact
that patients with CLBP were more sensitive to pressure
stimuli than were control subjects. The pain amplifica-
tion was also found in the patients with fibromyalgia in
this study, confirming previous fMRI findings in patients
with fibromyalgia (27). Central pain amplification has
further been noted in other idiopathic chronic pain
syndromes, such as irritable bowel syndrome (26). Our
results extend this finding of central pain amplification
to a group of individuals with chronic regional peri-
pheral pain syndromes such as low back pain.
In the healthy control subjects, a pressure stimu-
lus of 2 kg applied on the left thumb evoked only faint
pain and resulted in a significant increase of neural
activation in the contralateral S2 cortical region only.
Activations in S2 are commonly found during painful
stimulation (42), but are not specific to the evoked pain.
Activity in S2 has been described after nonpainful tactile
(43), electrical (44), and vibratory stimulation (45), and
thus S2 is considered to be a somatosensory integrative
area.
In the patients with CLBP and patients with
FMS, however, applying the same 2 kg of pressure,
which both groups rated as being moderately painful,
resulted in numerous significant neural activations of
pain-related brain areas. In addition to the contralateral
S2, the stimulus also caused significant increases in the
fMRI signal in the ipsilateral S2 and cerebellum, and in
the contralateral S1 and IPL. These regions of the brain
have all been implicated in pain processing with func-
tional roles, such as stimulus identification and encoding
(S1), attention (IPL), and motor response (cerebellum).
In contrast to the findings under the equal pres-
sure condition, the equal pain condition resulted in
qualitatively similar activations of the contralateral S1
and S2, ipsilateral S2, cerebellum, and the contralateral
IPL in all 3 groups. The magnitude of these activations,
however, was still greater in the CLBP and FMS groups.
Furthermore, in all 3 groups, we observed similar acti-
Table 3. Areas of neuronal activations under the equal pain condi-
tion (slightly intense pain)*
Side, cortical region, group x y z Z score
Contralateral
Primary somatosensory
HC 57 27 46 4.0843
CLBP 57 19 42 7.94725
FMS 57 13 43 5.39763
Secondary somatosensory
HC 55 21 12 4.59193
CLBP 61 15 14 7.72307
FMS 65 22 18 6.56891
Inferior parietal lobule
HC 53 44 50 3.60315
CLBP 51 46 48 3.7111
FMS 42 40 48 3.70678
Insula
HC 50 23 16 4.58386
CLBP 48 24 20 5.9398
FMS 40 2 9 5.06572
ACC
HC 2 4 46 3.86455
CLBP 2 12 42 3.94788
FMS 2 18 40 3.87204
Ipsilateral
Secondary somatosensory
HC 69 17 19 6.09707
CLBP 63 17 12 7.51685
FMS 67 17 10 6.88006
Cerebellum
HC 36 65 22 6.11633
CLBP 34 59 21 5.44895
FMS 34 61 22 7.10124
* ACC  anterior cingulate cortex (see Table 2 for other definitions).
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vations of the contralateral ACC, another area that has
been associated with perceived pain intensity (46).
Another significant neuronal activation in all 3
groups was observed in the contralateral insula. How-
ever, whereas the activations in the CLBP and healthy
control groups were correspondingly located in the
posterior insula, the activation in the FMS group was
located in a more anterior-inferior position. Although
frequently seen in pain studies, neither anterior nor
posterior insular responses are specific to pain (42).
Activation of the posterior insula has mostly been ob-
served as being associated with activation of S2, and very
often both activations overlap (21,45,47). The anterior
insula is consistently activated in emotional tasks with
negative affective components, such as tasting salt (48)
or viewing faces of disgust (49). The anterior insular
activation in the patients with FMS may indicate a
stronger affective response to the pain stimuli, which in
turn may be associated with their higher level of distress.
The enhanced response in the S1, S2, IPL, and
cerebellum contributes to the growing physical evidence
of altered physiologic processing in chronic pain condi-
tions such as CLBP and FMS. The association of CLBP
with a central disturbance in pain processing is congru-
ent with findings in other chronic pain states. Increased
pain sensitivity outside the areas of clinical pain has
been reported for other regional pain syndromes, such
as tension-type headache (50), temporomandibular dis-
order (51,52), and localized trapezius myalgia (18). Our
findings are also consistent with those of other studies
that have demonstrated lowered pain thresholds in
patients with low back pain (53) and lowered thresholds
in patients with regional or widespread pain who do not
have the 11 tender points required for the diagnosis of
fibromyalgia (54).
These results are also consistent with other func-
tional imaging studies that have suggested augmented
central pain processing in chronic pain conditions, in-
cluding fibromyalgia (27,55), irritable bowel syndrome
(26), cerebral infarction complicated by allodynia (56),
and atypical facial pain (57). In the only previous study
that used functional neuroimaging to assess patients
Figure 3. Overlapping neuronal activations under the equal pain condition. In the CLBP, FMS, and HC groups
under the equal pain condition, significant increases in pain-related neuronal activations (arrows) are demonstrated
in standard space superimposed on a structural T1-weighted magnetic resonance image. Images are shown in
radiologic view, with the right brain shown on the left. Overlapping activations appear in the indicated colors. Equal
subjective pain intensities result in 7 overlapping or adjacent areas of neuronal activation among the CLBP, HC, and
FMS groups (in the contralateral S1, S2, and IPL, anterior cingulate cortex [ACC], insula [not shown], and in
ipsilateral S2 and cerebellum). See Figure 2 for other definitions.
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with low back pain, Derbyshire et al used positron
emission tomography to compare cerebral responses to
heat stimulation in patients with CLBP and healthy
control subjects (58). That study found similar stimulus
encoding between groups, but did not examine differ-
ences in response to equally painful stimuli or test
differences in absolute response to equally intense stim-
ulation.
It is interesting to note that typical clinical testing
would not have detected the central pain amplification
in the CLBP group. The most common clinical test used
to detect diffuse tenderness is a tender point count. This
cohort of patients with CLBP had normal numbers of
tender points, and they were experiencing pain primarily
in the axial region, particularly the low back. Thus, they
were quite different clinically from the individuals with
fibromyalgia, whose condition was characterized by
chronic widespread pain and the presence of 11 (of 18)
tender points. However, when we evaluated the
pressure-pain sensitivity at a site distinct from their
region of pain (in this case, the thumbnail), the patients
with CLBP demonstrated increased tenderness similar
to that of the patients with FMS, who were tested in the
same manner.
The disparity between the tender point count and
the more sophisticated measures of tenderness is likely
due to external factors that influence easily biased
methods such as the tender point count (38,59). Wolfe
first noted the discrepancy between tender point counts
and other measures of tenderness, and also observed
that tender point counts are highly correlated with
distress, prompting the suggestion that tender points are
a “sedimentation rate for distress” (59). Subsequent
studies have confirmed the influence of distress on
clinical measures such as the tender point count, and the
lack of such influence on paradigms using random
stimulus application (60). As shown in Table 1, both the
levels of depressive symptoms and the extent of anxiety
were higher in the FMS group than in the CLBP group,
so this higher level of distress could have accounted for
the relatively higher tender point count in the FMS
group. It is also possible that patients with FMS “learn”
that tender points are areas where they are supposed to
be more tender, and thus report higher levels of pain on
palpation of these regions (61).
The present evidence of central pain augmenta-
tion represents an initial step in the evaluation of
potential central nervous system contributions to
chronic pain syndromes such as idiopathic CLBP and
fibromyalgia. Pressure-pain sensitivity is the hallmark
symptom of fibromyalgia, and several lines of experi-
mental evidence suggest that it is centrally mediated.
Recent studies suggest that many other regional pain
syndromes may likewise have primarily a central, rather
than a peripheral, basis, including not only irritable
bowel syndrome, but also temporomandibular syn-
drome, noncardiac chest pain, and interstitial cystitis,
among others. This spectrum of illness goes by many
different semantic terms (e.g., functional somatic syn-
dromes, somatoform disorders), and while the precise
cause remains unknown, there is unanimity that these
are very common symptoms and syndromes (62–64).
Preliminary studies such as this need replication
and extension. In addition to the small sample size in this
study, other possible problems are the recruitment of
subjects from tertiary care centers and newspapers, and
the fact that we did not control for the menstrual cycle of
the women. Nevertheless, if the symptoms in a substan-
tial number of individuals with CLBP are due to abnor-
mal central pain processing rather than due to damage
or inflammation of peripheral structures, this would
have enormous clinical implications. These data suggest
that the individual pain threshold should be evaluated in
clinical practice. The finding of a low pressure-pain
threshold at neutral sites (e.g., the thumbnail) might
indicate a central, rather than peripheral, cause for the
pain.
This information presented in this study may
guide treatment strategies. Drugs that affect central
levels of neuromodulators known to be involved in pain
processing (e.g., tricyclic antidepressants) are more ef-
fective in the management of centralized pain than are
alternate classes of compounds that work well for peri-
pheral pain (e.g., nonsteroidal antiinflammatory drugs
or opioids) (63,65). Similarly, nonpharmacologic thera-
pies, such as aerobic exercise and cognitive behavioral
therapy (66), can be especially useful adjuncts to treating
this constellation of chronic pain symptoms and syn-
dromes.
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